Directory
>
Mark Salvati
Mark Salvati
Ixebepilone Medical Lead, Global Medical Affairs | Regeneron
Los Angeles Metropolitan Area United States, United States
Mark Salvati
Summary
Mark Salvati is an accomplished leader in the field of oncology, currently serving as the Vice President and Global Program Head for Translational and Clinical Oncology at Regeneron. With a robust academic background, holding a Ph.D. in Organic Chemistry from UCLA, he has over a decade of experience in the pharmaceutical industry, particularly with Bristol Myers Squibb. Mark has a proven track record in leading cross-functional teams and executing complex clinical trials, notably in the development of groundbreaking cancer therapies. His strategic insights and dedication to medical affairs have significantly advanced cancer treatment protocols. He is well-versed in navigating the intricacies of oncology research and is passionate about improving patient outcomes through innovative therapies. Mark's career reflects a commitment to excellence and a drive for impactful results in clinical research.
Mark Salvati
Work Experience
Vice President at
Regeneron
March 2022 - Present
Mark Salvati
Education
University of California, Los Angeles, Doctor of Philosophy (Ph.D.), Organic Chemistry
January 1987 - January 1992
Frequently Asked Questions about Mark Salvati
What is Mark Salvati email address?
Mark Salvati's primary email address is ************@bms.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mark Salvati work for?
Mark Salvati is a Ixebepilone Medical Lead, Global Medical Affairs at Regeneron.
Where Mark Salvati graduated from?
Mark Salvati holds a degree in null from University of California, Los Angeles.
How can I directly contact Mark Salvati?
To contact Mark Salvati directly, you can use the email address ************@bms.com. Complete contact information is available upon registration with Muraena.
Who is Mark Salvati?
Mark Salvati is an accomplished leader in the field of oncology, currently serving as the Vice President and Global Program Head for Translational and Clinical Oncology at Regeneron. With a robust academic background, holding a Ph.D. in Organic Chemistry from UCLA, he has over a decade of experience in the pharmaceutical industry, particularly with Bristol Myers Squibb. Mark has a proven track record in leading cross-functional teams and executing complex clinical trials, notably in the development of groundbreaking cancer therapies. His strategic insights and dedication to medical affairs have significantly advanced cancer treatment protocols. He is well-versed in navigating the intricacies of oncology research and is passionate about improving patient outcomes through innovative therapies. Mark's career reflects a commitment to excellence and a drive for impactful results in clinical research.
Mark`s contact details
************@bms.com
********@amgen.com
************@regeneron.com
Colleagues
Scientist, Product Development
Program Director, Market Research
Associate Researcher
Previous Roles at Novartis
Vice President
Consultant in Rheumatology and Internal Medicine
Tax Senior
Program Director, Licensed Psychologist
Reporter
Research Training Specialist